Evaluation of Desmoglein-3 Autoantibodies in the Tissues of Oral Lichen Planus and Correlation with Disease Severity

计划入组 20 人 · 首次发布于 2024 年 10 月 22 日

Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

计划入组 133 人 · 首次发布于 2023 年 6 月 12 日

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

计划入组 40 人 · 首次发布于 2020 年 6 月 9 日

Triveni Bio Initiates First-in-Human Trial of TRIV-509 for Atopic Dermatitis, Targeting Novel Kallikrein Pathway

Cabaletta Bio's CAR-T Therapy Shows Promise Without Preconditioning in Pemphigus Vulgaris Trial